Will Stone
-
The peptide is supposed to deliver flawless and firm skin, promote wound healing and other anti-aging effects. So what's the evidence behind GHK-Cu?
-
A new study finds that an all-out sprint may have unique benefits when it comes to the proteins and tiny molecules in your bloodstream.
-
Oregon was the first state to establish a legalized and regulated psilocybin industry. Since then, thousands have tried magic mushrooms. Here is the latest data from the state's real-life experiment.
-
In some wellness circles, tadalafil is promoted as a longevity drug. There is evidence showing a link between it and a lower risk of death in men, but there are no well-controlled trials in humans.
-
The military plans to start screening service members for low testosterone, and social media is overflowing with claims about testosterone therapy. But who actually needs it?
-
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
-
Advisers to the Food and Drug Administration voted in favor of easing regulation of popular peptides. The recommendations could pave the way for specialized pharmacies to produce them in the U.S.
-
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.
-
Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to meet demand.
-
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.